R&D Tax Credit Assignment Program

The Pennsylvania Research and Development Tax Credit Assignment Program is a statutory mechanism allowing entities with approved, unused research credits to sell those credits to other taxpayers for immediate liquidity.

This program enables pre-revenue or low-liability innovators to monetize their tax assets while providing purchasers a structured means to reduce their state tax obligations by up to 75 percent.

The program represents a sophisticated integration of tax policy and economic development, designed specifically to bridge the gap between technical innovation and financial sustainability. Under Article XVII-B of the Tax Reform Code of 1971, the Commonwealth of Pennsylvania incentivizes the expansion of qualified research activities by providing credits based on incremental increases in research spending. While the credit is a powerful tool for reducing tax liability, its non-refundable nature often presents a hurdle for the very startups and high-growth technology firms that the state seeks to attract. For a business that is heavily invested in research but has not yet achieved profitability—and thus has no tax liability—a non-refundable credit is merely an accounting carryforward. The Assignment Program addresses this liquidity trap by authorizing the Department of Community and Economic Development (DCED) to approve the sale or assignment of these credits to third parties who possess the requisite tax liability to utilize them.

Statutory Framework and Legislative Evolution

The Pennsylvania Research and Development (R&D) Tax Credit was established by Act 7 of 1997, which introduced Article XVII-B into the Tax Reform Code of 1971. Since its inception, the program has undergone significant legislative refinements to expand its reach and improve its accessibility, particularly for the Commonwealth’s burgeoning technology sector. The initial legislative intent was to encourage taxpayers to increase R&D expenditures within Pennsylvania to enhance economic growth and job creation.

The legislative journey of the program is marked by several key updates. Act 40 of 2005 introduced definitions for pass-through entities and clarified the rules surrounding the assignment of credits, while Act 116 of 2006 doubled the credit rate for small businesses from 10 percent to 20 percent of the incremental increase in research expenses. This differentiation between "not small" and "small" businesses remains one of the program's most distinctive features, directly targeting the high-risk, high-reward nature of early-stage innovation.

Furthermore, Act 85 of 2016 made the R&D tax credit permanent by removing its sunset provision, and Act 53 of 2022 increased the annual program cap to $60 million, with a specific $12 million set-aside for small businesses. This set-aside is crucial, as it ensures that smaller firms are not crowded out by large, established corporations that typically account for the bulk of R&D spending in the state. The legislation also provides that the program cap may not be changed by the legislature before June 30, 2025, providing a stable planning horizon for companies considering large-scale Pennsylvania-based research projects.

Legislative Milestone	Key Provision and Impact	Statutory Reference
Act 7 of 1997	Established the R&D Tax Credit Program with an initial $15 million cap.	Article XVII-B, TRC 1971
Act 40 of 2005	Defined pass-through entities (S-Corps and Partnerships) and assignment rules.	Section 1702-B
Act 116 of 2006	Increased the credit rate for small businesses to 20 percent of excess expenses.	Section 1703-B
Act 85 of 2016	Made the credit program permanent by removing the sunset clause.	Article XVII-B
Act 43 of 2017	Mandated tax clearance to ensure applicants are compliant with all state taxes.	Section 1711-B
Act 25 of 2021	Established an appeals process and moved application deadlines to December 1.	Section 1703-B
Act 53 of 2022	Increased the annual cap to $60 million with a $12 million small business set-aside.	Section 1709-B

The administration of the credit is bifurcated between two state agencies. The Department of Revenue (DOR) is responsible for the technical evaluation of research activities, the calculation of the credit amount, and the issuance of the initial award. Conversely, the Department of Community and Economic Development (DCED) manages the Assignment Program, overseeing the subsequent sale of these credits on the open market. This division of labor allows tax experts to focus on compliance and technical definitions while development specialists focus on the economic impact of the credit's liquidity.

Definitions and Eligibility Criteria for Qualified Research

To participate in the Assignment Program, a taxpayer must first be awarded a credit, which requires conducting "Pennsylvania qualified research and development". The state’s definition of qualified research is largely tethered to the federal standards established under Section 41 of the Internal Revenue Code (IRC), but it adds a strict geographic requirement: the research must be conducted within the Commonwealth of Pennsylvania.

The Four-Part Test in the Pennsylvania Context

The Department of Revenue applies the federal "Four-Part Test" to determine if an activity qualifies for the credit. Taxpayers must demonstrate that their research activities meet each of the following criteria:

The research must be intended to develop a new business component or improve the functionality, performance, reliability, or quality of an existing business component. Routine quality control, market research, and cosmetic changes do not meet this standard.

The activity must be designed to discover information that would eliminate uncertainty concerning the development or improvement of the product or process. Uncertainty exists if the information available to the taxpayer does not establish either the capability or the specific method for developing the business component.

Substantially all of the activities must constitute a process of experimentation, which involves the identification of a hypothesis, the evaluation of alternatives, and the systematic testing of those alternatives through modeling, simulation, or trial-and-error.

The process of experimentation must rely on the principles of engineering, physics, chemistry, biology, or computer science. Research in the social sciences, arts, or humanities is explicitly excluded.

The "geographic nexus" is perhaps the most critical distinction for the state-level credit. A Pennsylvania-based company cannot claim the credit for research performed at its facility in another state, nor can it claim expenses for employees who work remotely from outside Pennsylvania, even if they are working on a Pennsylvania-based project.

Defining Small Business and Qualifying Entities

The program’s tiered structure provides significant advantages to "small businesses." Under Section 1702-B, a small business is defined as a for-profit corporation, limited liability company, partnership, or proprietorship with a net book value of assets totaling less than $5 million at either the beginning or the end of the taxable year for which the expenses were incurred. This determination is strictly based on the entity's balance sheet. Small businesses receive a 20 percent credit rate on their excess research expenses, effectively doubling the 10 percent rate granted to larger corporations.

A wide range of entity types are eligible to apply for the credit, including C-corporations, S-corporations, LLCs, and partnerships. For pass-through entities, the credit holds additional flexibility. If the entity itself cannot use the credit, it may elect to pass the credit through to its shareholders, members, or partners in proportion to their ownership interest. However, once a credit has been passed through to individual owners, it can no longer be sold or assigned by the entity.

The Mechanics of Credit Calculation and Proration

The Pennsylvania R&D tax credit is an incremental credit, meaning it does not reward total R&D spending, but rather the increase in R&D spending over a historical baseline. This structure is intended to incentivize continuous growth in innovation investment.

Determining the Pennsylvania Base Amount

The "base amount" represents the company's established level of research activity. For Pennsylvania purposes, the base amount is the greater of two figures:

1. The average Pennsylvania qualified research expenses (QREs) incurred during the four taxable years immediately preceding the year for which the credit is being sought.

2. Fifty percent of the Pennsylvania QREs for the current taxable year.

If a company has fewer than four years of spending history, the average is calculated based on the number of years available. However, a business must have at least two years of research spending history in Pennsylvania to be eligible for the credit. This "incremental" calculation means that companies with consistent, year-over-year growth in their research budgets derive the greatest benefit from the program.

Tentative vs. Actual Award and Proration

Because the total pool of available credits is capped at $60 million annually and the program is consistently oversubscribed, the Department of Revenue must apply a proration factor to all approved claims. When a business submits its application, it calculates a "tentative" credit based on its incremental spending. For a large business, this is 10 percent of the excess expenses over the base amount; for a small business, it is 20 percent.

After all applications are reviewed and the total amount of tentative credits is determined, the DOR reduces the awards proportionally to fit within the $60 million cap. Historically, large businesses have seen their tentative credits reduced significantly. For example, in recent program years, "not small" businesses received only 41.1 percent to 44.3 percent of their tentative awards. Conversely, small businesses often receive a higher percentage—and sometimes 100 percent—of their tentative requests because the total amount of small business claims frequently remains below the $12 million set-aside.

Business Category	Asset Threshold	Credit Rate	Annual Set-Aside	Typical Proration Factor
Large Business	$\ge \$5,000,000$	10% of Excess	$48,000,000	~41.1% to 45%
Small Business	$< \$5,000,000$	20% of Excess	$12,000,000	~100%

The Assignment Program: Liquidity and the Secondary Market

The core value of the Assignment Program lies in its ability to convert a non-refundable tax credit into immediate cash. This is particularly vital for the technology and manufacturing sectors, where companies may spend years in the R&D phase before reaching profitability.

Eligibility and Restrictions for Sellers (Assignors)

To sell or assign an R&D tax credit, a business (the seller or assignor) must meet specific statutory requirements. Most importantly, the seller must have possessed the credit for at least one year after it was approved by the Department of Revenue. For example, a credit approved by the DOR on May 1, 2024, would not be eligible for assignment until May 1, 2025. This one-year "holding period" is intended to encourage businesses to first attempt to use the credit against their own tax liabilities.

Furthermore, a business can only assign credits that have not already been used to offset a tax liability and that are still within their 15-year carryforward period. The amount eligible for assignment is also limited to the extent that the credit exceeds any collectible Pennsylvania tax liability the business currently owes. A business cannot sell a credit if it has outstanding tax debts to the Commonwealth; it must first use the credit to satisfy its own obligations.

The Role and Restrictions of the Buyer (Assignee)

The buyer (or assignee) is typically a profitable corporation or an individual with a significant Pennsylvania tax liability. By purchasing credits at a discount, the buyer reduces its effective tax rate. However, the law imposes several strict limitations on how these purchased credits can be used:

The most significant restriction is that purchased or assigned credits can only be applied against a maximum of 75 percent of the buyer's qualified tax liability for the taxable year. If a buyer has a tax liability of $1,000,000, they can only use $750,000 in purchased credits to satisfy it.

The buyer must claim the credit in the specific taxable year in which the DCED approval for the assignment is granted.

Unlike the original earner of the credit, the buyer has no carryforward or carryback rights. If the buyer does not have enough tax liability to use the full amount of the purchased credit in the year of assignment (subject to the 75 percent cap), the unused portion is lost entirely.

A buyer is strictly prohibited from reselling or reassigning the credits to another party. The assignment is a one-time transaction.

Credits can be applied against Corporate Net Income Tax (CNIT), Personal Income Tax (PIT), and historically, the Capital Stock and Franchise Tax (CSFT), though the latter has been phased out.

Market Dynamics and Brokerage

The secondary market for Pennsylvania R&D credits is highly active, with tech and manufacturing sectors showing the highest demand. Historically, credits have retained high value on the open market, often selling for approximately 92.9 percent of their face value. This small discount represents the buyer's incentive for participating in the program and managing the associated administrative requirements.

To facilitate these transactions, many companies use the services of agents, facilitators, or brokers. These brokers must register with the Department of Revenue. Their role is to match sellers who need cash with buyers who have high tax liabilities, ensuring that both parties meet the necessary compliance and clearance requirements.

Local State Revenue Office Guidance and Administrative Procedures

The administration of the R&D Tax Credit and its subsequent assignment is governed by rigorous procedural requirements and deadlines. Failure to adhere to these can result in the denial of the application or the forfeiture of the credit.

Application for the Initial Award (Department of Revenue)

The process begins with the submission of an application to the Department of Revenue through the myPATH online filing system. The application period typically opens on August 1 and closes on December 1. This application covers research expenses incurred during the taxable year that ended in the prior calendar year.

The application requires detailed information, including:

• Entity Information: Full legal name, FEIN/SSN, Revenue ID, and address.
• Federal Form 6765: A copy of the "Credit for Increasing Research Activities" form as filed with the IRS must be attached to the state application.
• Form REV-545: The state’s specific R&D credit calculation form.
• Project Descriptions: For each Pennsylvania-based project, the taxpayer must provide a narrative explaining how the project attempts to eliminate uncertainty, its process of experimentation, and its reliance on technological principles.
• Expenditure Breakdown: Detailed lists of direct wages paid, costs of supplies, and contract research expenses.
• Tax Clearance: The Department of Revenue performs a comprehensive tax clearance check on all applicants to ensure they are compliant with all state tax reporting and payment obligations.

The DOR is required to notify taxpayers of their approved credit amount by May 1 of the second calendar year following the close of the research year.

Application for Assignment (Department of Community and Economic Development)

Once a taxpayer has held an approved credit for one year, it may apply for assignment using Form DCED-RD-009, the "Application to Assign Research and Development Tax Credits". This two-page form is the primary administrative instrument for the secondary market.

The form consists of several critical sections:

• Section I: Prospective Seller or Assignor: Requires the seller's name, Revenue ID, the date the credits were issued, and the total amount of credits to be transferred. The seller must verify that it has filed its PA tax returns and is in full compliance with DOR requirements.
• Section II: Prospective Buyer or Assignee: Identifies the buyer and provides the necessary contact information for the issuance of the assignment approval letter.
• Section III: Information on the Assignment: Requires the disclosure of the agreed-upon sale price and identifies any agents or facilitators used in the transaction, including their fees.
• Section IV: Broker Registration: If a broker was used, their registration number must be provided.
• Section V: Utilization Rules Acknowledgment: The buyer must sign a certification, which must be notarized, acknowledging that it understands the 75 percent liability cap and the "no carryforward" rule.

The application must be received by the DCED Technology Investment Office on or before the last business day of the taxable year for which the credit will be used. The "Date of Approval" is established by the date the DCED receives the application.

Practical Example of the Assignment and the 75% Cap

To illustrate the financial and administrative impact of the Assignment Program, consider the following case study involving a small biotechnology firm and a large regional utility company.

The Seller: BioNext Solutions

BioNext Solutions is a small business with total assets of $3.5 million. In 2023, BioNext conducted extensive research in its Pittsburgh lab to develop a new enzyme for wastewater treatment.

• Current Year Pennsylvania QREs: $1,500,000.
• Prior 4-Year Average QREs: $500,000.
• Base Amount Calculation: $750,000 (The greater of the 4-year average of $500k or 50% of current year $1.5M).
• Excess QREs: $1,500,000 - $750,000 = $750,000.
• Tentative Credit: $150,000 (20% of the $750,000 excess, as they qualify as a small business).
• Award: Because small business claims were under the $12 million set-aside that year, the Department of Revenue issued an award for the full $150,000 on May 1, 2025.

The Transaction

BioNext is pre-revenue and has no Pennsylvania tax liability. In June 2026 (satisfying the one-year holding period), BioNext decides to sell its $150,000 credit. They use a registered broker to find a buyer, UtilityCorp.

• Sale Price: $0.93 per credit dollar.
• Cash to BioNext: $139,500 (immediate liquidity for further research).
• Broker Fee: $5,000 (paid by the seller).

The Buyer: UtilityCorp

UtilityCorp has a 2026 Pennsylvania Corporate Net Income Tax (CNIT) liability of $1,000,000. They apply for the assignment via Form DCED-RD-009, which is received by the DCED on October 1, 2026.

• Purchased Credit Amount: $150,000.
• Applying the 75% Cap: Legally, UtilityCorp can only offset up to 75 percent of its $1,000,000 liability.
• Maximum Offset Allowed: $750,000.
• Credit Utilization: Since the $150,000 purchased credit is less than the $750,000 cap, UtilityCorp can use the entire $150,000 in 2026.
• Net Tax Paid by UtilityCorp: $850,000.
• UtilityCorp's Net Benefit: They saved $150,000 in tax for a cash outlay of $139,500, resulting in a net gain of $10,500.

Risk Scenario: The "Loss of Value" Trigger

If UtilityCorp’s tax liability had only been $100,000 for the year 2026:

• Maximum Offset Allowed (75%): $75,000.
• Credit Application: Even though they purchased $150,000 in credits, they could only use $75,000.
• Result: The remaining $75,000 in purchased credits would expire and be lost forever, as buyers are prohibited from carrying credits forward to future years. This underscores the critical importance of precise tax liability forecasting for potential buyers.

Compliance, Fraud Prevention, and Audit Standards

The R&D tax credit is a high-scrutiny incentive due to its direct impact on the Commonwealth’s General Fund. Both the Department of Revenue and the Office of the Attorney General (OAG) have established rigorous compliance measures to protect the integrity of the program.

Independent Audits and Verification

Reflecting concerns about potential abuse, recent legislative trends and administrative guidance have increased the oversight of credit applications. A 2019 Grand Jury report recommended that applicants be subject to audits by independent certified public accountants and that the Commonwealth perform more frequent site visits to verify that research is actually being conducted at the claimed locations. The DOR now has the authority to conduct onsite audits and request additional documentation at its discretion. Failure to promptly respond to such requests can result in the immediate denial of an application or the subsequent request for the sale of a credit.

Record Retention Requirements

Taxpayers are required to maintain all records necessary to substantiate their R&D credit claim for at least five years post-application. These records must be more than just high-level financial statements; they must include:

• Payroll Records: Documentation showing the specific allocation of employee time to qualified research tasks vs. non-qualified activities.
• Technical Evidence: Lab notebooks, design specifications, testing protocols, and experimental results that demonstrate a systematic "process of experimentation".
• Project-Specific Accounting: Separate tracking of supplies and contract research costs for each Pennsylvania-based research project.

The Taxable Nature of Credit Sales

It is a common misconception that the cash received from the sale of a tax credit is tax-exempt. The Department of Revenue explicitly notes that the sale of a credit is a taxable transaction for income tax purposes. The seller must report the proceeds as income, and the Department provides information on these transactions to the IRS to ensure proper federal tax reporting. This effectively recaptures a portion of the incentive’s cost, as the "profit" from the sale is subject to federal and state income taxes.

Strategic Impact on Pennsylvania's Competitive Landscape

The Assignment Program serves as a unique economic engine that differentiates Pennsylvania from many of its peer states. While dozens of states offer R&D tax credits, Pennsylvania is one of only a handful—along with states like New Jersey—that provide a robust, state-sanctioned mechanism for the sale and transfer of these credits.

Supporting the Life Sciences and Tech Startups

The program is particularly vital for the life sciences sector, which is characterized by long development cycles and high capital requirements before a product reaches the market. For a pre-revenue biotech firm, the ability to generate six-figure cash inflows from their research efforts, even before they have a product to sell, can be the difference between completing a clinical trial and insolvency.

Broadening the Tax Base through Innovation

By encouraging businesses to conduct research in Pennsylvania, the credit helps build a highly skilled workforce of engineers, scientists, and technicians. While the credit reduces corporate tax revenue in the short term, the employment of these high-wage professionals generates Personal Income Tax (PIT) revenue for the state and stimulates local economies through increased spending.

Furthermore, the "75 percent rule" for buyers acts as a safeguard for the state budget. It ensures that even when credits are being utilized at a high rate, profitable corporations must still pay a significant portion of their tax bill in cash, preventing any single entity from completely zeroing out its contribution to the state’s revenue.

Summary of Utilization Rules: Seller vs. Buyer

The following table summarizes the key differences in how the R&D tax credit is utilized and managed depending on whether it is held by the original earner or a purchaser.

Rule Feature	Original Earner (Seller)	Purchaser (Buyer)
Max Tax Offset	100% of qualified tax liability	75% of qualified tax liability
Carryforward	Up to 15 succeeding taxable years	No carryforward; use in year of purchase
Carryback	No carryback allowed	No carryback allowed
Refundability	Non-refundable	Non-refundable
Assignability	Can be sold after 1-year holding period	Prohibited from resale or reassignment
Taxable Status	Sale proceeds are taxable income	N/A (purchased at a discount)
Filing Form	REV-545 (via myPATH)	DCED-RD-009 (Assignment Application)

Final Thoughts

The Pennsylvania Research and Development Tax Credit Assignment Program is a highly effective, albeit administratively complex, tool for fueling innovation within the Commonwealth. By allowing the secondary market to function as a source of non-dilutive capital, Pennsylvania has created a system that rewards technical excellence regardless of a firm's immediate profitability. The program’s success is built upon a foundation of strict federal technical standards, combined with state-specific safeguards like the 75 percent liability cap and the asset-based small business bonus.

For businesses operating in Pennsylvania, maximizing the value of the R&D credit requires a proactive approach to documentation and a deep understanding of the two-step administrative process involving both the Department of Revenue and the DCED. As the $60 million annual cap continues to be oversubscribed, the precision of a company's application—particularly in demonstrating the "Four-Part Test" and maintaining tax compliance—will remain the determining factor in securing these valuable financial resources. For the Commonwealth, the program remains a cornerstone of its economic strategy, ensuring that Pennsylvania remains a competitive destination for the global technology and manufacturing sectors.